Share this
Structure Therapeutics – $185.3 Million IPO
Apollo Endosurgery to Be Acquired by Boston Scientific
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion
Tmunity Therapeutics Agrees to Sell to Kite
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
ZitSticka sells to Heyday
Oyster Point Pharma to Be Acquired by Viatris
Tempus Labs – $175 Million in Funding
Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche
Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals
Cytokinetics – $450 Million Convertible Senior Notes Offering
Sixth Street Invests in Blueprint Medicines
Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion
Asymchem Agrees to Acquire Snapdragon Chemistry
Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion
Flexion Therapeutics Agrees to Sell to Pacira BioSciences
Warby Parker – Direct Listing
ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million
Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion
Lyell Immunopharma – $425 Million IPO
The Honest Company – $475 Million IPO
Five Prime Therapeutics Agrees to Sell to Amgen for $1.9 Billion
Horizon Therapeutics to Acquire Viela Bio
Celularity to Go Public Through SPAC Merger
Ovid - $75 Million IPO
VelosBio Agrees to Sell to Merck for $2.75 Billion
Genesis MedTech Acquires Drug Device Asset From TriReme Medical
Forbius Agrees to Sell to Bristol Myers Squibb
Neurocrine Partners With Takeda to Address Psychiatric Disorders
Orca Bio Raises $192 Million Series D to Transform Allogenic Cell Therapy
Avidity Biosciences - $289 Million IPO
Vaxcyte - $288 Million IPO
Fate Therapeutics Licensing and Platform Collaboration with Janssen Biotech
Forty Seven Agrees to Sell to Gilead for $4.9 Billion
Reata Pharmaceuticals – $505 Million Follow-On Offering
argenx – $557 Million Follow-On Offering
Synthorx to Sell to Sanofi for $2.5 Billion
Avidity Biosciences – $100 Million Series C
Innate Pharma - $79 Million IPO
Vir Biotechnology - $143 Million IPO
Bavarian Nordic Acquires Two Commercial Vaccines from GlaxoSmithKline for €796 Million
Crown Bioscience Enters Merger Agreement With JSR Corporation
Sucampo Sells to Mallinckrodt for $1.2 Billion
Cell Design Labs Sells to Gilead
ERYTECH – $144 Million IPO
Cooley Advises on Nightstar + NuCana IPOs
Zealand Pharma – $89 Million IPO
Aridis – $26 Million IPO
Horizon Pharma Buys River Vision for $145 Million and Unspecified Earn-Out
SELLAS Life Sciences Group to Merge with Galena Biopharma
ZELTIQ Aesthetics to Sell to Allergan for $2.5 Billion
Medivation Agrees to Sell to Pfizer for $14 Billion
Advaxis – $30 Million Registered Direct Offering
Recro Pharma – $15 Million Follow-On
Gemphire Therapeutics – $30 Million IPO
Syros – $58 Million IPO
Syros IPO – $58 Million
Selecta Biosciences – $74 Million IPO
Jazz Pharmaceuticals Acquires Celator for $1.5 Billion
Oncobiologics – $40 Million IPO and Private Placement
Inotek Pharmaceu